D Worm
Overview
Explore the profile of D Worm including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
669
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vienberg S, Jacobsen S, Worm D, Hvolris L, Naver L, Almdal T, et al.
Clin Endocrinol (Oxf)
. 2016 Sep;
86(1):156-159.
PMID: 27649688
Objective: The positive metabolic outcome of Roux-en-Y gastric bypass (RYGB) surgery may involve fibroblast growth factor 21 (FGF21), in both the fasting state and postprandially. We measured the fasting levels...
2.
Schmidt J, Pedersen S, Gregersen N, Vestergaard L, Nielsen M, Ritz C, et al.
Int J Obes (Lond)
. 2015 Aug;
40(2):281-90.
PMID: 26303352
Objectives: Increased energy expenditure (EE) has been proposed as an important mechanism for weight loss following Roux-en-Y gastric bypass (RYGB). However, this has never been investigated in a controlled setting...
3.
Dirksen C, Jorgensen N, Bojsen-Moller K, Kielgast U, Jacobsen S, Clausen T, et al.
Int J Obes (Lond)
. 2013 Feb;
37(11):1452-9.
PMID: 23419600
Objective: To identify factors contributing to the variation in weight loss after Roux-en-Y gastric bypass (RYGB). Design: Cross-sectional study of patients with good (excess body mass index lost (EBL) >60%)...
4.
Dirksen C, Damgaard M, Bojsen-Moller K, Jorgensen N, Kielgast U, Jacobsen S, et al.
Neurogastroenterol Motil
. 2013 Jan;
25(4):346-e255.
PMID: 23360316
Background: Roux-en-Y gastric bypass (RYGB) causes extensive changes in gastrointestinal anatomy and leads to reduced appetite and large weight loss, which partly is due to an exaggerated release of anorexigenic...
5.
Dirksen C, Jorgensen N, Bojsen-Moller K, Jacobsen S, Hansen D, Worm D, et al.
Diabetologia
. 2012 Apr;
55(7):1890-901.
PMID: 22538359
Roux-en-Y gastric bypass (RYGB) greatly improves glycaemic control in morbidly obese patients with type 2 diabetes, in many even before significant weight loss. Understanding the responsible mechanisms may contribute to...
6.
Jorgensen N, Jacobsen S, Dirksen C, Bojsen-Moller K, Naver L, Hvolris L, et al.
Am J Physiol Endocrinol Metab
. 2012 Apr;
303(1):E122-31.
PMID: 22535748
Our aim was to study the potential mechanisms responsible for the improvement in glucose control in Type 2 diabetes (T2D) within days after Roux-en-Y gastric bypass (RYGB). Thirteen obese subjects...
7.
Jacobsen S, Olesen S, Dirksen C, Jorgensen N, Bojsen-Moller K, Kielgast U, et al.
Obes Surg
. 2012 Feb;
22(7):1084-96.
PMID: 22359255
Background: Roux-en-Y gastric bypass (RYGB) surgery causes profound changes in secretion of gastrointestinal hormones and glucose metabolism. We present a detailed analysis of the early hormone changes after RYGB in...
8.
Larsen S, Stride N, Hey-Mogensen M, Hansen C, Andersen J, Madsbad S, et al.
Diabetologia
. 2011 Mar;
54(6):1427-36.
PMID: 21424396
Aims/hypothesis: Mitochondrial respiration has been linked to insulin resistance. We studied mitochondrial respiratory capacity and substrate sensitivity in patients with type 2 diabetes (patients), and obese and lean control participants....
9.
Worm D, Kirk O, Andersen O, Vinten J, Gerstoft J, Katzenstein T, et al.
HIV Med
. 2002 Nov;
3(4):239-46.
PMID: 12444941
Objective: To compare information on body fat changes from questionnaire and clinical examination and to study lipoatrophy in HIV-1 patients on highly active antiretroviral therapy (HAART). Methods: The study was...
10.
Worm D, Vinten J, Vaag A, Henriksen J, Beck-Nielsen H
Eur J Endocrinol
. 2000 Oct;
143(3):389-95.
PMID: 11022182
The effect of 3 days of intensive treatment with acipimox, an antilipolytic nicotinic acid derivative, on plasma leptin levels was studied in eight patients with Type 2 diabetes mellitus in...